Company intelligence / Profile preview
AmDerma Pharmaceuticals
Bridgewater, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
AmDerma Pharmaceuticals was a U.S. pharma company focused on dermatology and specialty topical products. It developed and commercialized drugs for skin and wound care, including FDA-approved econazole nitrate foam for tinea pedis, and licensed rights to Microcyn-based products for acne and atopic dermatitis. Its most advanced unapproved candidate, potassium dobesilate, reached Phase 2 for psoriasis. The company appears inactive as of 2025, though some of its products may remain on the market.
- Therapeutic areas
- Infectious DiseasesDermatology
- Modalities
- Small moleculeTopical formulationDermal delivery systemHydrogel-based drug delivery therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Oculus Innovative Sciences (Microcyn Technology license)
Beyond the preview
Go deeper on AmDerma Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AmDerma Pharmaceuticals.